LONDON – An experimental drug has demonstrated the ability to clear toxic tau tangles from the brain, a significant step…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions worldwide, the diagnosis of actinic keratosis (AK) marks the beginning of a challenging journey to prevent skin cancer.…
Read More
Pouring cold water on ALS progression: novel drug shields neurons from damage
Researchers at the University of Arizona (AZ, USA) have announced a significant advancement in the quest to combat Amyotrophic Lateral…
Read More
Unlocking Nature’s Pharmacy: Scientists Decipher Bacterial Secrets to Multi-Drug Cancer Therapies
For decades, the intricate molecular dance within bacteria that yields a remarkable array of potent anti-cancer compounds remained an enigma,…
Read More
How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director
The U.S. pharmaceutical landscape, historically characterized by higher drug prices compared to other developed nations, is undergoing a significant transformation,…
Read More
Bioengineered Human Bone Marrow-on-a-Chip Revolutionizes Drug Testing and Space Medicine Research
In a landmark achievement for bioengineering and regenerative medicine, a collaborative team of researchers from the University of Pennsylvania School…
Read More
Ginkgo, Tangible and Inductive Bio Launch ADME-One Platform to Revolutionize Early Drug Discovery Decisions with AI and Automation
A significant shift is underway in small-molecule drug discovery, as a new collaboration between Ginkgo Datapoints, Tangible Scientific, and Inductive…
Read More
AI-Driven Breakthrough Uncovers Novel Antibiotics to Combat the Global Threat of Drug-Resistant Gonorrhea
A groundbreaking study led by researchers from the Wyss Institute at Harvard University, MIT, and the Broad Institute of MIT…
Read More
Seven Pharma Companies Selected for FDA PreCheck Pilot Program to Bolster U.S. Drug Supply Chain
The U.S. Food and Drug Administration (FDA) has announced the initial cohort of seven pharmaceutical companies selected to participate in…
Read More
How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director
The United States healthcare system, grappling with persistently high drug costs, has seen significant shifts in its economic landscape, particularly…
Read MoreYOU MAY HAVE MISSED
